ARTICLE | Clinical News
Veletri epoprostenol regulatory update
July 29, 2013 7:00 AM UTC
Actelion disclosed in its 1H13 earnings that Veletri epoprostenol was approved in the Netherlands and the U.K. under the EU's decentralized procedure to treat pulmonary arterial hypertension (PAH). Th...